nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—prostate cancer	0.288	1	CbGaD
Magnesium salicylate—ALB—Abiraterone—prostate cancer	0.128	0.304	CbGbCtD
Magnesium salicylate—ALB—Estrone—prostate cancer	0.0924	0.22	CbGbCtD
Magnesium salicylate—PTGS2—Etoposide—prostate cancer	0.0549	0.131	CbGbCtD
Magnesium salicylate—ALB—Estradiol—prostate cancer	0.0531	0.126	CbGbCtD
Magnesium salicylate—PTGS1—Etoposide—prostate cancer	0.0464	0.11	CbGbCtD
Magnesium salicylate—ALB—Prednisone—prostate cancer	0.0456	0.109	CbGbCtD
Magnesium salicylate—Carbamazepine—RALBP1—prostate cancer	0.000897	0.177	CrCbGaD
Magnesium salicylate—Trisalicylate-choline—PTGS2—prostate cancer	0.000614	0.122	CrCbGaD
Magnesium salicylate—Deferasirox—CYP3A4—prostate cancer	0.000574	0.114	CrCbGaD
Magnesium salicylate—Salicylate-sodium—PTGS2—prostate cancer	0.000372	0.0737	CrCbGaD
Magnesium salicylate—Ketoprofen—CXCL8—prostate cancer	0.000363	0.0718	CrCbGaD
Magnesium salicylate—Oxcarbazepine—CYP3A5—prostate cancer	0.000355	0.0702	CrCbGaD
Magnesium salicylate—Erythema—Mitoxantrone—prostate cancer	0.000282	0.00164	CcSEcCtD
Magnesium salicylate—Headache—Bicalutamide—prostate cancer	0.00028	0.00163	CcSEcCtD
Magnesium salicylate—Somnolence—Goserelin—prostate cancer	0.000277	0.00161	CcSEcCtD
Magnesium salicylate—Dysgeusia—Mitoxantrone—prostate cancer	0.000276	0.0016	CcSEcCtD
Magnesium salicylate—Oesophagitis—Epirubicin—prostate cancer	0.000274	0.00159	CcSEcCtD
Magnesium salicylate—Somnolence—Conjugated Estrogens—prostate cancer	0.000274	0.00159	CcSEcCtD
Magnesium salicylate—Dyspepsia—Goserelin—prostate cancer	0.000274	0.00159	CcSEcCtD
Magnesium salicylate—Ecchymosis—Epirubicin—prostate cancer	0.000272	0.00158	CcSEcCtD
Magnesium salicylate—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000271	0.00158	CcSEcCtD
Magnesium salicylate—Asthma—Capecitabine—prostate cancer	0.00027	0.00157	CcSEcCtD
Magnesium salicylate—Decreased appetite—Goserelin—prostate cancer	0.00027	0.00157	CcSEcCtD
Magnesium salicylate—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000268	0.00156	CcSEcCtD
Magnesium salicylate—Pruritus—Ethinyl Estradiol—prostate cancer	0.000267	0.00155	CcSEcCtD
Magnesium salicylate—Pain—Goserelin—prostate cancer	0.000266	0.00155	CcSEcCtD
Magnesium salicylate—Constipation—Goserelin—prostate cancer	0.000266	0.00155	CcSEcCtD
Magnesium salicylate—Nausea—Bicalutamide—prostate cancer	0.000266	0.00154	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Doxorubicin—prostate cancer	0.000265	0.00154	CcSEcCtD
Magnesium salicylate—Pain—Conjugated Estrogens—prostate cancer	0.000264	0.00153	CcSEcCtD
Magnesium salicylate—Constipation—Conjugated Estrogens—prostate cancer	0.000264	0.00153	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—prostate cancer	0.000261	0.0516	CrCbGaD
Magnesium salicylate—Abdominal discomfort—Capecitabine—prostate cancer	0.000259	0.00151	CcSEcCtD
Magnesium salicylate—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000259	0.0015	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Goserelin—prostate cancer	0.000256	0.00149	CcSEcCtD
Magnesium salicylate—Olsalazine—PTGS2—prostate cancer	0.000255	0.0505	CrCbGaD
Magnesium salicylate—Erythema multiforme—Etoposide—prostate cancer	0.000254	0.00148	CcSEcCtD
Magnesium salicylate—Weight increased—Docetaxel—prostate cancer	0.000254	0.00148	CcSEcCtD
Magnesium salicylate—Oesophagitis—Doxorubicin—prostate cancer	0.000254	0.00147	CcSEcCtD
Magnesium salicylate—Ecchymosis—Doxorubicin—prostate cancer	0.000251	0.00146	CcSEcCtD
Magnesium salicylate—Dizziness—Ethinyl Estradiol—prostate cancer	0.00025	0.00145	CcSEcCtD
Magnesium salicylate—Flushing—Etoposide—prostate cancer	0.00025	0.00145	CcSEcCtD
Magnesium salicylate—Confusional state—Estradiol—prostate cancer	0.000249	0.00144	CcSEcCtD
Magnesium salicylate—Urticaria—Goserelin—prostate cancer	0.000247	0.00144	CcSEcCtD
Magnesium salicylate—Oedema—Estradiol—prostate cancer	0.000247	0.00143	CcSEcCtD
Magnesium salicylate—Weight increased—Capecitabine—prostate cancer	0.000246	0.00143	CcSEcCtD
Magnesium salicylate—Urticaria—Conjugated Estrogens—prostate cancer	0.000245	0.00142	CcSEcCtD
Magnesium salicylate—Shock—Estradiol—prostate cancer	0.000243	0.00141	CcSEcCtD
Magnesium salicylate—Carbamazepine—CYP3A5—prostate cancer	0.000242	0.0479	CrCbGaD
Magnesium salicylate—Oxcarbazepine—CYP2C19—prostate cancer	0.000241	0.0478	CrCbGaD
Magnesium salicylate—Vomiting—Ethinyl Estradiol—prostate cancer	0.00024	0.0014	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Estradiol—prostate cancer	0.000238	0.00138	CcSEcCtD
Magnesium salicylate—Rash—Ethinyl Estradiol—prostate cancer	0.000238	0.00138	CcSEcCtD
Magnesium salicylate—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000238	0.00138	CcSEcCtD
Magnesium salicylate—Headache—Ethinyl Estradiol—prostate cancer	0.000237	0.00138	CcSEcCtD
Magnesium salicylate—Epistaxis—Docetaxel—prostate cancer	0.000235	0.00136	CcSEcCtD
Magnesium salicylate—Confusional state—Mitoxantrone—prostate cancer	0.000232	0.00135	CcSEcCtD
Magnesium salicylate—Oedema—Mitoxantrone—prostate cancer	0.00023	0.00133	CcSEcCtD
Magnesium salicylate—Dysgeusia—Etoposide—prostate cancer	0.000229	0.00133	CcSEcCtD
Magnesium salicylate—Epistaxis—Capecitabine—prostate cancer	0.000227	0.00132	CcSEcCtD
Magnesium salicylate—Shock—Mitoxantrone—prostate cancer	0.000226	0.00131	CcSEcCtD
Magnesium salicylate—Nausea—Ethinyl Estradiol—prostate cancer	0.000225	0.0013	CcSEcCtD
Magnesium salicylate—Hepatitis—Docetaxel—prostate cancer	0.000224	0.0013	CcSEcCtD
Magnesium salicylate—Lethargy—Epirubicin—prostate cancer	0.000222	0.00129	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000222	0.00129	CcSEcCtD
Magnesium salicylate—Pruritus—Goserelin—prostate cancer	0.00022	0.00128	CcSEcCtD
Magnesium salicylate—Somnolence—Estradiol—prostate cancer	0.000219	0.00127	CcSEcCtD
Magnesium salicylate—Weight increased—Prednisone—prostate cancer	0.000219	0.00127	CcSEcCtD
Magnesium salicylate—Anorexia—Mitoxantrone—prostate cancer	0.000219	0.00127	CcSEcCtD
Magnesium salicylate—Pruritus—Conjugated Estrogens—prostate cancer	0.000218	0.00127	CcSEcCtD
Magnesium salicylate—Dyspepsia—Estradiol—prostate cancer	0.000217	0.00126	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS2—prostate cancer	0.000217	0.0429	CrCbGaD
Magnesium salicylate—Hepatitis—Capecitabine—prostate cancer	0.000216	0.00126	CcSEcCtD
Magnesium salicylate—Hypotension—Mitoxantrone—prostate cancer	0.000215	0.00125	CcSEcCtD
Magnesium salicylate—Decreased appetite—Estradiol—prostate cancer	0.000214	0.00125	CcSEcCtD
Magnesium salicylate—Diarrhoea—Goserelin—prostate cancer	0.000213	0.00124	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Docetaxel—prostate cancer	0.000211	0.00123	CcSEcCtD
Magnesium salicylate—Pain—Estradiol—prostate cancer	0.000211	0.00122	CcSEcCtD
Magnesium salicylate—Constipation—Estradiol—prostate cancer	0.000211	0.00122	CcSEcCtD
Magnesium salicylate—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000211	0.00122	CcSEcCtD
Magnesium salicylate—Flushing—Docetaxel—prostate cancer	0.000208	0.00121	CcSEcCtD
Magnesium salicylate—Lethargy—Doxorubicin—prostate cancer	0.000206	0.0012	CcSEcCtD
Magnesium salicylate—Dizziness—Goserelin—prostate cancer	0.000206	0.00119	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Capecitabine—prostate cancer	0.000205	0.00119	CcSEcCtD
Magnesium salicylate—Somnolence—Mitoxantrone—prostate cancer	0.000204	0.00119	CcSEcCtD
Magnesium salicylate—Dizziness—Conjugated Estrogens—prostate cancer	0.000204	0.00118	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Estradiol—prostate cancer	0.000203	0.00118	CcSEcCtD
Magnesium salicylate—Dyspepsia—Mitoxantrone—prostate cancer	0.000202	0.00117	CcSEcCtD
Magnesium salicylate—Tinnitus—Capecitabine—prostate cancer	0.000202	0.00117	CcSEcCtD
Magnesium salicylate—Flushing—Capecitabine—prostate cancer	0.000201	0.00117	CcSEcCtD
Magnesium salicylate—Decreased appetite—Mitoxantrone—prostate cancer	0.0002	0.00116	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Epirubicin—prostate cancer	0.000199	0.00116	CcSEcCtD
Magnesium salicylate—Vomiting—Goserelin—prostate cancer	0.000198	0.00115	CcSEcCtD
Magnesium salicylate—Pain—Mitoxantrone—prostate cancer	0.000197	0.00114	CcSEcCtD
Magnesium salicylate—Constipation—Mitoxantrone—prostate cancer	0.000197	0.00114	CcSEcCtD
Magnesium salicylate—Rash—Goserelin—prostate cancer	0.000196	0.00114	CcSEcCtD
Magnesium salicylate—Dermatitis—Goserelin—prostate cancer	0.000196	0.00114	CcSEcCtD
Magnesium salicylate—Vomiting—Conjugated Estrogens—prostate cancer	0.000196	0.00114	CcSEcCtD
Magnesium salicylate—Urticaria—Estradiol—prostate cancer	0.000196	0.00114	CcSEcCtD
Magnesium salicylate—Headache—Goserelin—prostate cancer	0.000195	0.00113	CcSEcCtD
Magnesium salicylate—Erythema—Docetaxel—prostate cancer	0.000195	0.00113	CcSEcCtD
Magnesium salicylate—Rash—Conjugated Estrogens—prostate cancer	0.000194	0.00113	CcSEcCtD
Magnesium salicylate—Dermatitis—Conjugated Estrogens—prostate cancer	0.000194	0.00113	CcSEcCtD
Magnesium salicylate—Headache—Conjugated Estrogens—prostate cancer	0.000193	0.00112	CcSEcCtD
Magnesium salicylate—Confusional state—Etoposide—prostate cancer	0.000193	0.00112	CcSEcCtD
Magnesium salicylate—Hallucination—Prednisone—prostate cancer	0.000192	0.00111	CcSEcCtD
Magnesium salicylate—Dysgeusia—Docetaxel—prostate cancer	0.000191	0.00111	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Mitoxantrone—prostate cancer	0.000189	0.0011	CcSEcCtD
Magnesium salicylate—Erythema—Capecitabine—prostate cancer	0.000188	0.00109	CcSEcCtD
Magnesium salicylate—Asthma—Epirubicin—prostate cancer	0.000188	0.00109	CcSEcCtD
Magnesium salicylate—Nausea—Goserelin—prostate cancer	0.000185	0.00107	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Etoposide—prostate cancer	0.000185	0.00107	CcSEcCtD
Magnesium salicylate—Dysgeusia—Capecitabine—prostate cancer	0.000185	0.00107	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Doxorubicin—prostate cancer	0.000184	0.00107	CcSEcCtD
Magnesium salicylate—Nausea—Conjugated Estrogens—prostate cancer	0.000183	0.00106	CcSEcCtD
Magnesium salicylate—Urticaria—Mitoxantrone—prostate cancer	0.000183	0.00106	CcSEcCtD
Magnesium salicylate—Anorexia—Etoposide—prostate cancer	0.000182	0.00106	CcSEcCtD
Magnesium salicylate—Flushing—Prednisone—prostate cancer	0.000179	0.00104	CcSEcCtD
Magnesium salicylate—Hypotension—Etoposide—prostate cancer	0.000179	0.00104	CcSEcCtD
Magnesium salicylate—Pruritus—Estradiol—prostate cancer	0.000174	0.00101	CcSEcCtD
Magnesium salicylate—Asthma—Doxorubicin—prostate cancer	0.000174	0.00101	CcSEcCtD
Magnesium salicylate—Weight increased—Epirubicin—prostate cancer	0.000171	0.000996	CcSEcCtD
Magnesium salicylate—Somnolence—Etoposide—prostate cancer	0.00017	0.000987	CcSEcCtD
Magnesium salicylate—Diarrhoea—Estradiol—prostate cancer	0.000169	0.00098	CcSEcCtD
Magnesium salicylate—Drowsiness—Epirubicin—prostate cancer	0.000168	0.000976	CcSEcCtD
Magnesium salicylate—Erythema—Prednisone—prostate cancer	0.000168	0.000975	CcSEcCtD
Magnesium salicylate—Decreased appetite—Etoposide—prostate cancer	0.000166	0.000965	CcSEcCtD
Magnesium salicylate—Carbamazepine—CYP2C19—prostate cancer	0.000165	0.0326	CrCbGaD
Magnesium salicylate—Pain—Etoposide—prostate cancer	0.000163	0.000949	CcSEcCtD
Magnesium salicylate—Constipation—Etoposide—prostate cancer	0.000163	0.000949	CcSEcCtD
Magnesium salicylate—Dizziness—Estradiol—prostate cancer	0.000163	0.000947	CcSEcCtD
Magnesium salicylate—Sweating—Epirubicin—prostate cancer	0.000161	0.000935	CcSEcCtD
Magnesium salicylate—Confusional state—Docetaxel—prostate cancer	0.00016	0.00093	CcSEcCtD
Magnesium salicylate—Oedema—Docetaxel—prostate cancer	0.000159	0.000923	CcSEcCtD
Magnesium salicylate—Weight increased—Doxorubicin—prostate cancer	0.000159	0.000922	CcSEcCtD
Magnesium salicylate—Epistaxis—Epirubicin—prostate cancer	0.000158	0.00092	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Etoposide—prostate cancer	0.000158	0.000915	CcSEcCtD
Magnesium salicylate—Diarrhoea—Mitoxantrone—prostate cancer	0.000157	0.000913	CcSEcCtD
Magnesium salicylate—Vomiting—Estradiol—prostate cancer	0.000157	0.000911	CcSEcCtD
Magnesium salicylate—Shock—Docetaxel—prostate cancer	0.000156	0.000908	CcSEcCtD
Magnesium salicylate—Rash—Estradiol—prostate cancer	0.000155	0.000903	CcSEcCtD
Magnesium salicylate—Drowsiness—Doxorubicin—prostate cancer	0.000155	0.000903	CcSEcCtD
Magnesium salicylate—Dermatitis—Estradiol—prostate cancer	0.000155	0.000902	CcSEcCtD
Magnesium salicylate—Confusional state—Capecitabine—prostate cancer	0.000155	0.000901	CcSEcCtD
Magnesium salicylate—Headache—Estradiol—prostate cancer	0.000154	0.000897	CcSEcCtD
Magnesium salicylate—Oedema—Capecitabine—prostate cancer	0.000154	0.000893	CcSEcCtD
Magnesium salicylate—Oxcarbazepine—CYP3A4—prostate cancer	0.000154	0.0304	CrCbGaD
Magnesium salicylate—Urticaria—Etoposide—prostate cancer	0.000152	0.000882	CcSEcCtD
Magnesium salicylate—Anorexia—Docetaxel—prostate cancer	0.000151	0.000879	CcSEcCtD
Magnesium salicylate—Shock—Capecitabine—prostate cancer	0.000151	0.000879	CcSEcCtD
Magnesium salicylate—Hepatitis—Epirubicin—prostate cancer	0.000151	0.000876	CcSEcCtD
Magnesium salicylate—Sweating—Doxorubicin—prostate cancer	0.000149	0.000866	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Capecitabine—prostate cancer	0.000149	0.000864	CcSEcCtD
Magnesium salicylate—Hypotension—Docetaxel—prostate cancer	0.000148	0.000862	CcSEcCtD
Magnesium salicylate—Epistaxis—Doxorubicin—prostate cancer	0.000147	0.000852	CcSEcCtD
Magnesium salicylate—Anorexia—Capecitabine—prostate cancer	0.000147	0.000851	CcSEcCtD
Magnesium salicylate—Nausea—Estradiol—prostate cancer	0.000146	0.000851	CcSEcCtD
Magnesium salicylate—Vomiting—Mitoxantrone—prostate cancer	0.000146	0.000849	CcSEcCtD
Magnesium salicylate—Rash—Mitoxantrone—prostate cancer	0.000145	0.000842	CcSEcCtD
Magnesium salicylate—Dermatitis—Mitoxantrone—prostate cancer	0.000145	0.000841	CcSEcCtD
Magnesium salicylate—Headache—Mitoxantrone—prostate cancer	0.000144	0.000836	CcSEcCtD
Magnesium salicylate—Hypotension—Capecitabine—prostate cancer	0.000144	0.000835	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Epirubicin—prostate cancer	0.000143	0.000828	CcSEcCtD
Magnesium salicylate—Somnolence—Docetaxel—prostate cancer	0.000141	0.00082	CcSEcCtD
Magnesium salicylate—Tinnitus—Epirubicin—prostate cancer	0.000141	0.000817	CcSEcCtD
Magnesium salicylate—Flushing—Epirubicin—prostate cancer	0.00014	0.000813	CcSEcCtD
Magnesium salicylate—Dyspepsia—Docetaxel—prostate cancer	0.00014	0.000812	CcSEcCtD
Magnesium salicylate—Hepatitis—Doxorubicin—prostate cancer	0.00014	0.00081	CcSEcCtD
Magnesium salicylate—Decreased appetite—Docetaxel—prostate cancer	0.000138	0.000802	CcSEcCtD
Magnesium salicylate—Oedema—Prednisone—prostate cancer	0.000137	0.000796	CcSEcCtD
Magnesium salicylate—Nausea—Mitoxantrone—prostate cancer	0.000136	0.000793	CcSEcCtD
Magnesium salicylate—Pain—Docetaxel—prostate cancer	0.000136	0.000789	CcSEcCtD
Magnesium salicylate—Constipation—Docetaxel—prostate cancer	0.000136	0.000789	CcSEcCtD
Magnesium salicylate—Dyspepsia—Capecitabine—prostate cancer	0.000135	0.000786	CcSEcCtD
Magnesium salicylate—Pruritus—Etoposide—prostate cancer	0.000135	0.000785	CcSEcCtD
Magnesium salicylate—Shock—Prednisone—prostate cancer	0.000135	0.000783	CcSEcCtD
Magnesium salicylate—Decreased appetite—Capecitabine—prostate cancer	0.000134	0.000777	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—prostate cancer	0.000133	0.0264	CrCbGaD
Magnesium salicylate—Hyperhidrosis—Prednisone—prostate cancer	0.000132	0.000769	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Doxorubicin—prostate cancer	0.000132	0.000766	CcSEcCtD
Magnesium salicylate—Pain—Capecitabine—prostate cancer	0.000132	0.000764	CcSEcCtD
Magnesium salicylate—Constipation—Capecitabine—prostate cancer	0.000132	0.000764	CcSEcCtD
Magnesium salicylate—Erythema—Epirubicin—prostate cancer	0.000131	0.000763	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Docetaxel—prostate cancer	0.000131	0.00076	CcSEcCtD
Magnesium salicylate—Diarrhoea—Etoposide—prostate cancer	0.000131	0.00076	CcSEcCtD
Magnesium salicylate—Anorexia—Prednisone—prostate cancer	0.000131	0.000758	CcSEcCtD
Magnesium salicylate—Tinnitus—Doxorubicin—prostate cancer	0.00013	0.000756	CcSEcCtD
Magnesium salicylate—Flushing—Doxorubicin—prostate cancer	0.00013	0.000752	CcSEcCtD
Magnesium salicylate—Dysgeusia—Epirubicin—prostate cancer	0.000129	0.000747	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Capecitabine—prostate cancer	0.000127	0.000736	CcSEcCtD
Magnesium salicylate—Dizziness—Etoposide—prostate cancer	0.000126	0.000734	CcSEcCtD
Magnesium salicylate—Urticaria—Capecitabine—prostate cancer	0.000122	0.00071	CcSEcCtD
Magnesium salicylate—Vomiting—Etoposide—prostate cancer	0.000122	0.000706	CcSEcCtD
Magnesium salicylate—Erythema—Doxorubicin—prostate cancer	0.000121	0.000706	CcSEcCtD
Magnesium salicylate—Dyspepsia—Prednisone—prostate cancer	0.000121	0.0007	CcSEcCtD
Magnesium salicylate—Rash—Etoposide—prostate cancer	0.000121	0.0007	CcSEcCtD
Magnesium salicylate—Dermatitis—Etoposide—prostate cancer	0.00012	0.000699	CcSEcCtD
Magnesium salicylate—Headache—Etoposide—prostate cancer	0.00012	0.000695	CcSEcCtD
Magnesium salicylate—Decreased appetite—Prednisone—prostate cancer	0.000119	0.000692	CcSEcCtD
Magnesium salicylate—Dysgeusia—Doxorubicin—prostate cancer	0.000119	0.000691	CcSEcCtD
Magnesium salicylate—Constipation—Prednisone—prostate cancer	0.000117	0.00068	CcSEcCtD
Magnesium salicylate—Nausea—Etoposide—prostate cancer	0.000114	0.000659	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Prednisone—prostate cancer	0.000113	0.000656	CcSEcCtD
Magnesium salicylate—Pruritus—Docetaxel—prostate cancer	0.000112	0.000653	CcSEcCtD
Magnesium salicylate—Urticaria—Prednisone—prostate cancer	0.000109	0.000632	CcSEcCtD
Magnesium salicylate—Pruritus—Capecitabine—prostate cancer	0.000109	0.000632	CcSEcCtD
Magnesium salicylate—Diarrhoea—Docetaxel—prostate cancer	0.000109	0.000631	CcSEcCtD
Magnesium salicylate—Confusional state—Epirubicin—prostate cancer	0.000108	0.000627	CcSEcCtD
Magnesium salicylate—Oedema—Epirubicin—prostate cancer	0.000107	0.000622	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS2—prostate cancer	0.000106	0.0209	CrCbGaD
Magnesium salicylate—Shock—Epirubicin—prostate cancer	0.000105	0.000612	CcSEcCtD
Magnesium salicylate—Diarrhoea—Capecitabine—prostate cancer	0.000105	0.000611	CcSEcCtD
Magnesium salicylate—Dizziness—Docetaxel—prostate cancer	0.000105	0.00061	CcSEcCtD
Magnesium salicylate—Carbamazepine—CYP3A4—prostate cancer	0.000105	0.0207	CrCbGaD
Magnesium salicylate—Hyperhidrosis—Epirubicin—prostate cancer	0.000104	0.000602	CcSEcCtD
Magnesium salicylate—Anorexia—Epirubicin—prostate cancer	0.000102	0.000593	CcSEcCtD
Magnesium salicylate—Dizziness—Capecitabine—prostate cancer	0.000102	0.000591	CcSEcCtD
Magnesium salicylate—Vomiting—Docetaxel—prostate cancer	0.000101	0.000587	CcSEcCtD
Magnesium salicylate—Rash—Docetaxel—prostate cancer	0.0001	0.000582	CcSEcCtD
Magnesium salicylate—Hypotension—Epirubicin—prostate cancer	0.0001	0.000582	CcSEcCtD
Magnesium salicylate—Dermatitis—Docetaxel—prostate cancer	0.0001	0.000581	CcSEcCtD
Magnesium salicylate—Confusional state—Doxorubicin—prostate cancer	0.0001	0.000581	CcSEcCtD
Magnesium salicylate—Headache—Docetaxel—prostate cancer	9.95e-05	0.000578	CcSEcCtD
Magnesium salicylate—Oedema—Doxorubicin—prostate cancer	9.91e-05	0.000576	CcSEcCtD
Magnesium salicylate—Vomiting—Capecitabine—prostate cancer	9.78e-05	0.000568	CcSEcCtD
Magnesium salicylate—Shock—Doxorubicin—prostate cancer	9.75e-05	0.000567	CcSEcCtD
Magnesium salicylate—Rash—Capecitabine—prostate cancer	9.7e-05	0.000563	CcSEcCtD
Magnesium salicylate—Pruritus—Prednisone—prostate cancer	9.69e-05	0.000563	CcSEcCtD
Magnesium salicylate—Dermatitis—Capecitabine—prostate cancer	9.69e-05	0.000563	CcSEcCtD
Magnesium salicylate—Headache—Capecitabine—prostate cancer	9.63e-05	0.00056	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Doxorubicin—prostate cancer	9.58e-05	0.000557	CcSEcCtD
Magnesium salicylate—Somnolence—Epirubicin—prostate cancer	9.52e-05	0.000553	CcSEcCtD
Magnesium salicylate—Anorexia—Doxorubicin—prostate cancer	9.45e-05	0.000549	CcSEcCtD
Magnesium salicylate—Nausea—Docetaxel—prostate cancer	9.44e-05	0.000548	CcSEcCtD
Magnesium salicylate—Dyspepsia—Epirubicin—prostate cancer	9.43e-05	0.000548	CcSEcCtD
Magnesium salicylate—Diarrhoea—Prednisone—prostate cancer	9.37e-05	0.000544	CcSEcCtD
Magnesium salicylate—Decreased appetite—Epirubicin—prostate cancer	9.31e-05	0.000541	CcSEcCtD
Magnesium salicylate—Hypotension—Doxorubicin—prostate cancer	9.26e-05	0.000538	CcSEcCtD
Magnesium salicylate—Pain—Epirubicin—prostate cancer	9.16e-05	0.000532	CcSEcCtD
Magnesium salicylate—Constipation—Epirubicin—prostate cancer	9.16e-05	0.000532	CcSEcCtD
Magnesium salicylate—Nausea—Capecitabine—prostate cancer	9.14e-05	0.000531	CcSEcCtD
Magnesium salicylate—Dizziness—Prednisone—prostate cancer	9.06e-05	0.000526	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Epirubicin—prostate cancer	8.83e-05	0.000513	CcSEcCtD
Magnesium salicylate—Somnolence—Doxorubicin—prostate cancer	8.81e-05	0.000512	CcSEcCtD
Magnesium salicylate—Dyspepsia—Doxorubicin—prostate cancer	8.73e-05	0.000507	CcSEcCtD
Magnesium salicylate—Vomiting—Prednisone—prostate cancer	8.71e-05	0.000506	CcSEcCtD
Magnesium salicylate—Rash—Prednisone—prostate cancer	8.64e-05	0.000502	CcSEcCtD
Magnesium salicylate—Dermatitis—Prednisone—prostate cancer	8.63e-05	0.000501	CcSEcCtD
Magnesium salicylate—Decreased appetite—Doxorubicin—prostate cancer	8.62e-05	0.000501	CcSEcCtD
Magnesium salicylate—Headache—Prednisone—prostate cancer	8.58e-05	0.000498	CcSEcCtD
Magnesium salicylate—Urticaria—Epirubicin—prostate cancer	8.51e-05	0.000494	CcSEcCtD
Magnesium salicylate—Pain—Doxorubicin—prostate cancer	8.48e-05	0.000492	CcSEcCtD
Magnesium salicylate—Constipation—Doxorubicin—prostate cancer	8.48e-05	0.000492	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Doxorubicin—prostate cancer	8.17e-05	0.000474	CcSEcCtD
Magnesium salicylate—Nausea—Prednisone—prostate cancer	8.14e-05	0.000473	CcSEcCtD
Magnesium salicylate—Urticaria—Doxorubicin—prostate cancer	7.88e-05	0.000457	CcSEcCtD
Magnesium salicylate—Pruritus—Epirubicin—prostate cancer	7.58e-05	0.00044	CcSEcCtD
Magnesium salicylate—Diarrhoea—Epirubicin—prostate cancer	7.33e-05	0.000426	CcSEcCtD
Magnesium salicylate—Dizziness—Epirubicin—prostate cancer	7.09e-05	0.000412	CcSEcCtD
Magnesium salicylate—Pruritus—Doxorubicin—prostate cancer	7.01e-05	0.000407	CcSEcCtD
Magnesium salicylate—Vomiting—Epirubicin—prostate cancer	6.81e-05	0.000396	CcSEcCtD
Magnesium salicylate—Diarrhoea—Doxorubicin—prostate cancer	6.78e-05	0.000394	CcSEcCtD
Magnesium salicylate—Rash—Epirubicin—prostate cancer	6.76e-05	0.000392	CcSEcCtD
Magnesium salicylate—Dermatitis—Epirubicin—prostate cancer	6.75e-05	0.000392	CcSEcCtD
Magnesium salicylate—Headache—Epirubicin—prostate cancer	6.71e-05	0.00039	CcSEcCtD
Magnesium salicylate—Dizziness—Doxorubicin—prostate cancer	6.56e-05	0.000381	CcSEcCtD
Magnesium salicylate—Nausea—Epirubicin—prostate cancer	6.36e-05	0.00037	CcSEcCtD
Magnesium salicylate—Vomiting—Doxorubicin—prostate cancer	6.3e-05	0.000366	CcSEcCtD
Magnesium salicylate—Rash—Doxorubicin—prostate cancer	6.25e-05	0.000363	CcSEcCtD
Magnesium salicylate—Dermatitis—Doxorubicin—prostate cancer	6.24e-05	0.000363	CcSEcCtD
Magnesium salicylate—Headache—Doxorubicin—prostate cancer	6.21e-05	0.000361	CcSEcCtD
Magnesium salicylate—Nausea—Doxorubicin—prostate cancer	5.89e-05	0.000342	CcSEcCtD
Magnesium salicylate—PTGS2—Metabolism—SLC22A1—prostate cancer	2.1e-05	0.000183	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.09e-05	0.000182	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HSD3B1—prostate cancer	2.08e-05	0.000181	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC22A3—prostate cancer	2.08e-05	0.000181	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—B2M—prostate cancer	2.08e-05	0.000181	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFBR1—prostate cancer	2.08e-05	0.000181	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.07e-05	0.000181	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SULT2A1—prostate cancer	2.04e-05	0.000178	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.04e-05	0.000178	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RPS19—prostate cancer	2.04e-05	0.000178	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKR1C3—prostate cancer	2.04e-05	0.000178	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PRKACB—prostate cancer	2.03e-05	0.000177	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NCOA2—prostate cancer	2.02e-05	0.000176	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.02e-05	0.000176	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MED12—prostate cancer	2.01e-05	0.000175	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	2e-05	0.000174	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TBXAS1—prostate cancer	2e-05	0.000174	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTA4—prostate cancer	2e-05	0.000174	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GNG5—prostate cancer	2e-05	0.000174	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PPP3CA—prostate cancer	1.98e-05	0.000172	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.95e-05	0.00017	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	1.95e-05	0.00017	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTA2—prostate cancer	1.95e-05	0.000169	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC5A5—prostate cancer	1.93e-05	0.000168	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NCOA3—prostate cancer	1.92e-05	0.000167	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCG5—prostate cancer	1.92e-05	0.000167	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SULT1A1—prostate cancer	1.92e-05	0.000167	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PRKCZ—prostate cancer	1.92e-05	0.000167	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.89e-05	0.000165	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLAU—prostate cancer	1.89e-05	0.000164	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP2E1—prostate cancer	1.88e-05	0.000164	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CALR—prostate cancer	1.88e-05	0.000164	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTA1—prostate cancer	1.88e-05	0.000163	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NQO1—prostate cancer	1.86e-05	0.000162	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NAT2—prostate cancer	1.86e-05	0.000162	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTO1—prostate cancer	1.86e-05	0.000162	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HSD3B2—prostate cancer	1.86e-05	0.000162	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PARP1—prostate cancer	1.85e-05	0.000161	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGFR4—prostate cancer	1.85e-05	0.000161	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CAV1—prostate cancer	1.84e-05	0.000161	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TH—prostate cancer	1.84e-05	0.00016	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HPGDS—prostate cancer	1.83e-05	0.00016	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CALCA—prostate cancer	1.83e-05	0.000159	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.82e-05	0.000159	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2C19—prostate cancer	1.82e-05	0.000159	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP3A4—prostate cancer	1.82e-05	0.000158	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.81e-05	0.000157	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	1.79e-05	0.000156	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1B1—prostate cancer	1.79e-05	0.000155	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.78e-05	0.000155	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PLCB2—prostate cancer	1.78e-05	0.000155	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2C18—prostate cancer	1.78e-05	0.000155	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—LRP2—prostate cancer	1.78e-05	0.000155	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTT1—prostate cancer	1.78e-05	0.000155	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ACHE—prostate cancer	1.78e-05	0.000155	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2A6—prostate cancer	1.76e-05	0.000153	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HSPA1A—prostate cancer	1.75e-05	0.000153	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.75e-05	0.000153	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—P4HB—prostate cancer	1.74e-05	0.000152	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GGT1—prostate cancer	1.73e-05	0.000151	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.73e-05	0.00015	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKR1C3—prostate cancer	1.71e-05	0.000149	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NCOA1—prostate cancer	1.7e-05	0.000148	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PRKACB—prostate cancer	1.7e-05	0.000148	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC22A1—prostate cancer	1.7e-05	0.000148	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	1.7e-05	0.000148	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP17A1—prostate cancer	1.68e-05	0.000147	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CASP9—prostate cancer	1.68e-05	0.000146	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CG—prostate cancer	1.68e-05	0.000146	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP19A1—prostate cancer	1.68e-05	0.000146	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.68e-05	0.000146	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.66e-05	0.000145	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—EGF—prostate cancer	1.66e-05	0.000145	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SULT2A1—prostate cancer	1.65e-05	0.000144	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PRKCQ—prostate cancer	1.63e-05	0.000142	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MED12—prostate cancer	1.63e-05	0.000142	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—RXRA—prostate cancer	1.62e-05	0.000141	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GNG5—prostate cancer	1.61e-05	0.000141	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NCOA2—prostate cancer	1.6e-05	0.00014	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.58e-05	0.000137	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—COMT—prostate cancer	1.56e-05	0.000136	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CREBBP—prostate cancer	1.56e-05	0.000136	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NCOA3—prostate cancer	1.56e-05	0.000135	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTP1—prostate cancer	1.55e-05	0.000135	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGF10—prostate cancer	1.55e-05	0.000135	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IGF1—prostate cancer	1.54e-05	0.000134	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC5A5—prostate cancer	1.53e-05	0.000133	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.53e-05	0.000133	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ITPR1—prostate cancer	1.53e-05	0.000133	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.52e-05	0.000133	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.5e-05	0.000131	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP2E1—prostate cancer	1.49e-05	0.00013	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HPGDS—prostate cancer	1.48e-05	0.000129	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NQO1—prostate cancer	1.48e-05	0.000129	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CD—prostate cancer	1.48e-05	0.000129	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2C19—prostate cancer	1.47e-05	0.000128	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFBR2—prostate cancer	1.47e-05	0.000128	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SERPINE1—prostate cancer	1.46e-05	0.000127	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TH—prostate cancer	1.46e-05	0.000127	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ITPR1—prostate cancer	1.45e-05	0.000126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.45e-05	0.000126	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TYMS—prostate cancer	1.44e-05	0.000126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP3A4—prostate cancer	1.44e-05	0.000126	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTT1—prostate cancer	1.44e-05	0.000125	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ACHE—prostate cancer	1.44e-05	0.000125	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTM1—prostate cancer	1.43e-05	0.000124	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2A6—prostate cancer	1.42e-05	0.000124	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1B1—prostate cancer	1.42e-05	0.000123	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.42e-05	0.000123	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—LPL—prostate cancer	1.4e-05	0.000122	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS3—prostate cancer	1.39e-05	0.000121	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKR1C3—prostate cancer	1.38e-05	0.000121	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PRKACB—prostate cancer	1.38e-05	0.00012	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GGT1—prostate cancer	1.37e-05	0.00012	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP17A1—prostate cancer	1.36e-05	0.000119	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—JAK2—prostate cancer	1.35e-05	0.000118	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1A1—prostate cancer	1.35e-05	0.000118	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NCOA1—prostate cancer	1.35e-05	0.000118	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.35e-05	0.000117	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.34e-05	0.000117	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ERCC2—prostate cancer	1.34e-05	0.000117	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP19A1—prostate cancer	1.33e-05	0.000116	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LPL—prostate cancer	1.33e-05	0.000116	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PDGFRB—prostate cancer	1.32e-05	0.000115	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NCOA2—prostate cancer	1.3e-05	0.000113	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CB—prostate cancer	1.29e-05	0.000112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—RXRA—prostate cancer	1.29e-05	0.000112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERCC2—prostate cancer	1.27e-05	0.000111	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—MTHFR—prostate cancer	1.26e-05	0.00011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.25e-05	0.000109	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB3—prostate cancer	1.24e-05	0.000108	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.24e-05	0.000108	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGFR2—prostate cancer	1.24e-05	0.000108	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—COMT—prostate cancer	1.24e-05	0.000108	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC5A5—prostate cancer	1.24e-05	0.000108	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PPARA—prostate cancer	1.24e-05	0.000108	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTP1—prostate cancer	1.23e-05	0.000107	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ITPR1—prostate cancer	1.21e-05	0.000106	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP2E1—prostate cancer	1.21e-05	0.000105	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NQO1—prostate cancer	1.2e-05	0.000104	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTHFR—prostate cancer	1.2e-05	0.000104	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.19e-05	0.000104	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TERT—prostate cancer	1.19e-05	0.000104	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2—prostate cancer	1.18e-05	0.000103	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TH—prostate cancer	1.18e-05	0.000103	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.17e-05	0.000102	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP3A4—prostate cancer	1.17e-05	0.000102	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CAV1—prostate cancer	1.16e-05	0.000101	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.16e-05	0.000101	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1B1—prostate cancer	1.15e-05	9.99e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TYMS—prostate cancer	1.15e-05	9.98e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HIF1A—prostate cancer	1.14e-05	9.93e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTM1—prostate cancer	1.13e-05	9.87e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—LPL—prostate cancer	1.11e-05	9.69e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.11e-05	9.68e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GGT1—prostate cancer	1.11e-05	9.67e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CAV1—prostate cancer	1.1e-05	9.61e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NCOA1—prostate cancer	1.09e-05	9.53e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP19A1—prostate cancer	1.08e-05	9.39e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1A1—prostate cancer	1.07e-05	9.35e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ERCC2—prostate cancer	1.07e-05	9.28e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—EP300—prostate cancer	1.06e-05	9.23e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CG—prostate cancer	1.06e-05	9.23e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—RXRA—prostate cancer	1.04e-05	9.06e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BAD—prostate cancer	1.04e-05	9.03e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SRC—prostate cancer	1.03e-05	8.98e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.01e-05	8.81e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APC—prostate cancer	1e-05	8.75e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—prostate cancer	1e-05	8.74e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—INS—prostate cancer	1e-05	8.74e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—COMT—prostate cancer	1e-05	8.73e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MTHFR—prostate cancer	1e-05	8.72e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTP1—prostate cancer	9.97e-06	8.69e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGF—prostate cancer	9.93e-06	8.65e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IRS1—prostate cancer	9.93e-06	8.65e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CREBBP—prostate cancer	9.82e-06	8.56e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PPARA—prostate cancer	9.82e-06	8.56e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ITPR1—prostate cancer	9.81e-06	8.55e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.65e-06	8.41e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GSK3B—prostate cancer	9.64e-06	8.4e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—INS—prostate cancer	9.51e-06	8.28e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CD—prostate cancer	9.32e-06	8.11e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CREBBP—prostate cancer	9.31e-06	8.11e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TYMS—prostate cancer	9.27e-06	8.08e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CAV1—prostate cancer	9.24e-06	8.04e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB1—prostate cancer	9.21e-06	8.03e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTM1—prostate cancer	9.17e-06	7.98e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—LPL—prostate cancer	9e-06	7.84e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAP2K1—prostate cancer	8.89e-06	7.74e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CD—prostate cancer	8.83e-06	7.69e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.82e-06	7.69e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—NOS3—prostate cancer	8.8e-06	7.66e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SERPINE1—prostate cancer	8.73e-06	7.61e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1A1—prostate cancer	8.69e-06	7.57e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ERCC2—prostate cancer	8.62e-06	7.51e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KRAS—prostate cancer	8.53e-06	7.43e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGF2—prostate cancer	8.45e-06	7.36e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CG—prostate cancer	8.41e-06	7.33e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS3—prostate cancer	8.34e-06	7.26e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CB—prostate cancer	8.12e-06	7.07e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JAK2—prostate cancer	8.1e-06	7.06e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MTHFR—prostate cancer	8.1e-06	7.06e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—prostate cancer	8.05e-06	7.01e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—INS—prostate cancer	7.96e-06	6.94e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PPARA—prostate cancer	7.95e-06	6.92e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MDM2—prostate cancer	7.91e-06	6.89e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—prostate cancer	7.84e-06	6.83e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CREBBP—prostate cancer	7.8e-06	6.79e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB2—prostate cancer	7.8e-06	6.79e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CB—prostate cancer	7.7e-06	6.7e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—prostate cancer	7.59e-06	6.61e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CAV1—prostate cancer	7.47e-06	6.51e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CD—prostate cancer	7.4e-06	6.44e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1B—prostate cancer	7.22e-06	6.29e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.14e-06	6.22e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTEN—prostate cancer	7.02e-06	6.11e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—NOS3—prostate cancer	6.98e-06	6.08e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CTNNB1—prostate cancer	6.82e-06	5.94e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CG—prostate cancer	6.81e-06	5.93e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—EP300—prostate cancer	6.69e-06	5.83e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1A—prostate cancer	6.67e-06	5.81e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTEN—prostate cancer	6.65e-06	5.79e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CB—prostate cancer	6.45e-06	5.61e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—INS—prostate cancer	6.44e-06	5.61e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT1—prostate cancer	6.41e-06	5.58e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EP300—prostate cancer	6.34e-06	5.52e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CREBBP—prostate cancer	6.31e-06	5.5e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SRC—prostate cancer	6.17e-06	5.37e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CD—prostate cancer	5.98e-06	5.21e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT3—prostate cancer	5.95e-06	5.18e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—NOS3—prostate cancer	5.65e-06	4.92e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTEN—prostate cancer	5.57e-06	4.85e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—prostate cancer	5.53e-06	4.81e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFB1—prostate cancer	5.51e-06	4.8e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGFR—prostate cancer	5.41e-06	4.71e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—EP300—prostate cancer	5.31e-06	4.63e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CB—prostate cancer	5.22e-06	4.54e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—prostate cancer	5.17e-06	4.5e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KRAS—prostate cancer	5.11e-06	4.45e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—prostate cancer	4.95e-06	4.31e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—prostate cancer	4.69e-06	4.09e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTEN—prostate cancer	4.51e-06	3.93e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—EP300—prostate cancer	4.3e-06	3.74e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6—prostate cancer	4.15e-06	3.62e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKT1—prostate cancer	4.04e-06	3.52e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—prostate cancer	3.93e-06	3.42e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT1—prostate cancer	3.83e-06	3.34e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKT1—prostate cancer	3.21e-06	2.8e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—prostate cancer	3.18e-06	2.77e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKT1—prostate cancer	2.6e-06	2.26e-05	CbGpPWpGaD
